Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995 | MicrobiomeTrials← Back to trialsNCT02116764
Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995
CompletedOBSERVATIONAL
Trial Details
Start: 2014-06-11Est. Completion: 2022-06-02
Enrollment target: 137 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
HIVCancerChronic Granulomatous DiseaseDock 8 Deficiency
Background:
\- There are very few documents to help young adults living with advanced cancer discuss their concerns and…
Orange, United StatesCompleted Aug 16, 2023
Lung Cancer
The goal of this observational study is to learn whether a urine-based test that measures volatile organic compounds (VO…
Philadelphia, United StatesEst. completion Mar 1, 2028
EARLY_PHASE1
Recruiting
Chronic Granulomatous Disease
Background:
CGD causes infections and inflammation. The only cure currently is a bone marrow transplant. Most often a p…
Bethesda, United StatesEst. completion Jun 15, 2034